FDA inspection

National Centre for Nuclear Research: FDA inspection ending Feb 7, 2019

FDA inspection 1083211 · Voluntary Action Indicated (VAI) · Otwock-Swierk

Key facts

Inspection ID 1083211
Firm National Centre for Nuclear Research
FEI number 3008592343
Address Radioisotope Centre Polatom, Andrzej Soltan 7 Street
City Otwock-Swierk
Fiscal year 2019
Inspection end date Feb 7, 2019
Classification Voluntary Action Indicated (VAI)
Project area Generic Drug Evaluation
Product type Drugs

At a glance

  • None Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections